Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $58.1K | $75.3K |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $159.0K | $543.2K |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | −$101.0K | −$468.0K |
| Gross margin | — | — | — | — | — | — | -173.8% | -621.4% |
| R&D | $0 | $0 | $446.7K | $1.7M | $5.4M | $4.5M | $5.8M | $5.9M |
| Operating income | −$86.0K | −$165.0K | −$1.0M | −$4.0M | −$8.3M | −$7.4M | −$9.8M | −$10.6M |
| EBITDA | −$86.0K | −$165.0K | $2.5M | −$3.9M | −$8.2M | −$6.9M | −$9.3M | −$10.1M |
| Net income | −$85.5K | −$150.0K | −$4.5M | −$4.0M | −$8.3M | −$7.6M | −$10.0M | −$10.6M |
| Net margin | — | — | — | — | — | — | -17145.8% | -14101.0% |
| EPS (diluted) | -0.01 | -0.02 | -0.17 | -0.08 | -0.13 | -0.10 | -0.10 | -0.09 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds LXXGF.
No tracked institution reports a position in LXXGF as of their last filing.
No one on the platform has traded LXXGF yet.
| $11M |
| — |
| EIGRQEiger BioPharmaceuticals, Inc. | $8.50 | +6.25% | $13M | — |
| LVCLYLiving Cell Technologies Limited | $0.03 | +24.39% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$LXXGF I was cleaning out my SSD and came across this gem. Remember the bogus "EUA" announcement they did to goose the share price? I also have the video file that they quickly deleted from their then website if the SEC ever wants that piece of evidence.
View on StockTwits ↗$LXXGF Jack and Meridian conspired to eliminate their loyal investors and file CH7. They already had plans to start the new company and ask for new investors money. We knew they were being successful with the biopharma companies but they filed anyway to ditch us. Personally I hope they fail. All of us should have been swept into their new company with the same amount of shares. I filed with the SEC which is derelict and fraudulent as well. Jack showed his home address once on Linkedin. If anyone finds it send it to me. Thx
View on StockTwits ↗$LXXGF Lexagene is back ??? https://manta-bio.com/markets/ Our Story After earning his PhD at UCSF, Dr. Regan was recruited by Lawrence Livermore National Laboratory, where he developed advanced bio-warfare surveillance and respiratory pathogen detection systems for the U.S. Department of Homeland Security’s BioWatch program. Drawing from his experience in both government and the diagnostics industry, he founded MantaBio to bring cutting-edge genetic testing to underserved markets.
View on StockTwits ↗$LXXGF Schwab did a courtesy sell for me at zero dollars. It will be reported on my 1099 this year. I hope Jack and his buddies rots in hell.
View on StockTwits ↗$LXXGF t I think there’s a procedure you can do with your broker to make it worthless I forget what like deliver the certificates You tell the IRS it’s zero Will they complain? They have bigger fish to fry Not financial advice just dug deeper Not the first time such things have happen Jacks new nickname could be Jack Shat or similar if it won’t get you banned
View on StockTwits ↗$LXXGF Shareholders are not technically creditors of the estate. They hold equity interests in the Debtor and receive distributions only in the event that there are surplus proceeds after payment of all allowed claims in the case, with interest. Lezagene shareholders are equity holders of Lexagene Holdings, Inc. Before any distribution can be made to the shareholders of Lexagene Holdings, Inc., all pre-petition obligations of Lexagene, Inc and Lexagene Holdings, Inc., must be satisfied in full. Once I completed liquidation of estate assets in mid-2023, and based upon the amount of claims filed in the case, it was apparent that there would be insufficient funds on hand to satisfy the claims filed in the Lexagene, Inc. case. As a result, it was also clear at that time that no surplus funds would be available to pay Lexagene Holdings, Inc. claims or to make distributions to shareholders of Lexagene Holdings, Inc.
View on StockTwits ↗$LXXGF From John the Ch7 trustee. As you likely know, the Bankruptcy Code provides for equality of distribution of all available funds to similarly situated creditors. It also provides for a priority of distribution among different classes of creditors. I like to think of it as a ladder. Each class of creditors represents a rung on the ladder. All creditors occupying the highest rung must be paid in full before distributions can be made to members of the next rung, and so forth until there are insufficient funds available to pay members of a particular rung in full. At that point, each member receives a pro rata distribution (based on the amounts of their claims) of all remaining funds. Once the funds are depleted, no further distributions can be made.
View on StockTwits ↗$LXXGF The word "accounts" in my previous post should have been "accountants". John says his letter satisfies accountants that the IRS will accept it in order to write off the LXXGF investment.
View on StockTwits ↗$LXXGF I have been in contact with the Ch7 administrator. John has informed me that LexaGene has been delisted from the Canadian stock exchnge TSX because they no longer met the requirements. That has not happened here in the US on the OTC. John is saying he has no ability to request the OTC delist LXXGF. He has written a letter that satisfies accounts so all investors can write off the stock to zero. I can try to post his letter but it may be too large for all of it to be posted. I will send it to the people on our email list as well. John said the largest share holder was Merician who owned 18,500,000 shs and they were satisfied with the letter in order to write it off. So was Jack and Jeff.
View on StockTwits ↗$LXXGF This is all bullshit! Look at how they promote their product; the same as they promoted before with the same Big Bio Pharma prospects and even referring back to the MiQ 1 as they call it. What happened to the liquidation? They are at the same location with all the same equipment. Who is to say that the same employees weren't given a severance to get them from the LXXGF INC to Lexagene Life Sciences. They say the majority shareholder set up this LLC. How did they do that without us shareholders at the time being aware of it. So rather than get financing or selling us to a possible buyer, Jack elected to screw us and take some leadership role. They are even working with Livermore Institute still. So does Meridian own it now? If they had done everything they could have, I would just have accepted it as a bad investment but I hate being intentionally screwed by a guy who would take time out of a conference to take your personal call. I guess to promote the company!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.